Cogent Biosciences’ $150 Million Upsized Shares Offering and Pre-funded Warrants

Laura Testa
Tagged:

Latham & Watkins represented the underwriters in the offering.Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, executed an…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now